We are live on ! Find out more
GNPX icon

Genprex
GNPX

18 hedge funds and large institutions have $5.85M invested in Genprex in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

223% more call options, than puts

Call options by funds: $384K | Put options by funds: $119K

0% less ownership

Funds ownership: 0% → 0% (-0%)

8% less capital invested

Capital invested by funds: $6.33M → $5.85M (-$485K)

10% less funds holding

Funds holding: 20 → 18 (-2)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
5
Closed
2
Calls
$384K
Puts
$119K
Net Calls
+$265K
Net Calls Change
-$317K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$56.5K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$56.5K

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$113K
2
Millennium Management
Millennium Management
New York
-$113K
3
UBS Group
UBS Group
Switzerland
-$113K
4
Renaissance Technologies
Renaissance Technologies
New York
-$56.5K
5
Simplex Trading
Simplex Trading
Illinois
-$56.5K

GNPX Hedge Fund Activity: Q4 2022 in Review

18 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2022, worth a combined $5.85M — down 7.7% from $6.33M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of GNPX and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $56.5K. The largest seller was Group One Trading, cutting an estimated $113K.

  • 18 institutional investors held Genprex (GNPX) as of Q4 2022, down from 20 in Q3 2022.
  • Funds reported $5.85M of Genprex stock for Q4 2022, down 7.7% quarter-over-quarter.
  • 1 fund opened new Genprex positions in Q4 2022 and 2 closed out, a net change of -1 holder.
  • The largest Genprex buyer in Q4 2022 was Citadel Advisors, an estimated $56.5K added.
  • The largest Genprex seller in Q4 2022 was Group One Trading, an estimated $113K sold.

Based on aggregated 13F filings for Q4 2022.